Quantum Cyber N.V. Cash Flows From Used In Investing Activities
Quantum Cyber N.V. (QUCY) reported Cash Flows From Used In Investing Activities of -$451.12 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2025-09-26
- Quantum Cyber N.V. cash flows from used in investing activities for the quarter ending 2023-12-31 was -$261.81K.
- Quantum Cyber N.V. cash flows from used in investing activities for the quarter ending 2023-09-30 was -$112.48K.
- Quantum Cyber N.V. cash flows from used in investing activities for the quarter ending 2023-06-30 was -$123.63K.
- Quantum Cyber N.V. cash flows from used in investing activities for the quarter ending 2023-03-31 was -$1.40M.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$451.12K 6-K · filed 2025-09-26 | |||
| 2024-12-31 | -$198.82K 20-F · filed 2025-03-31 | |||
| 2024-06-30 | -$420.66K 6-K · filed 2025-09-26 | |||
| 2023-12-31 | -$261.81K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$374.29K derived: sum of 2 quarters · filed 2025-03-31 | -$497.91K derived: sum of 3 quarters · filed 2025-03-31 | -$1.90M 20-F · filed 2025-03-31 |
| 2023-09-30 | -$112.48K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$236.10K derived: sum of 2 quarters · filed 2024-10-18 | -$1.64M 6-K · filed 2023-11-16 | -$1.65M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$123.63K derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | -$1.52M 6-K · filed 2024-10-18 | -$1.54M derived: sum of 3 quarters · filed 2025-03-31 | -$1.93M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$1.40M 6-K · filed 2023-05-16 | -$1.42M derived: sum of 2 quarters · filed 2025-03-31 | -$1.81M derived: sum of 3 quarters · filed 2025-03-31 | -$1.98M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$14.85K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$406.04K derived: sum of 2 quarters · filed 2025-03-31 | -$582.62K derived: sum of 3 quarters · filed 2025-03-31 | -$658.48K 20-F · filed 2025-03-31 |
| 2022-09-30 | -$391.19K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$567.78K derived: sum of 2 quarters · filed 2023-11-16 | -$643.64K 6-K · filed 2023-11-16 | |
| 2022-06-30 | -$176.59K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$252.45K 6-K · filed 2023-08-15 | ||
| 2022-03-31 | -$75.86K 6-K · filed 2023-05-16 | |||
| 2021-12-31 | $1.20M 20-F · filed 2024-04-09 | |||
| 2021-06-30 | -$4.58K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | -$9.69K 20-F · filed 2023-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |